ReP USP - Resultado da busca

Artigo de periodico
Disease safety, immunogenicity, and efficacy of recombinant Herpes Zoster Vaccine (RZV or Shingrix) in autoimmune rheumatic diseases: launching a randomized phase 4 study (2025)
Kupa, Leonard V. K.; Medeiros-Ribeiro, Ana Cristina; Aikawa, Nadia E.; Pasoto, Sandra G.; Borba Neto, Eduardo Ferreira ; Assad, Ana Paula L.; SAAD, Carla G. S.; Shinjo, Samuel Katsuyuki ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: JCR-Journal of Clinical Rheumatology. Unidade: FM
Subjects: IMUNOGENICIDADE DA VACINA, HERPES ZOSTER, ESTUDOS RANDOMIZADOS, PLACEBOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard V. K. et al. Disease safety, immunogenicity, and efficacy of recombinant Herpes Zoster Vaccine (RZV or Shingrix) in autoimmune rheumatic diseases: launching a randomized phase 4 study. JCR-Journal of Clinical Rheumatology, v. 31, n. 6, p. e104-e111, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/89117. Acesso em: 01 maio 2026.
APA
Kupa, L. V. K., Medeiros-Ribeiro, A. C., Aikawa, N. E., Pasoto, S. G., Borba Neto, E. F., Assad, A. P. L., et al. (2025). Disease safety, immunogenicity, and efficacy of recombinant Herpes Zoster Vaccine (RZV or Shingrix) in autoimmune rheumatic diseases: launching a randomized phase 4 study. JCR-Journal of Clinical Rheumatology, 31( 6), e104-e111. doi:10.1097/RHU.0000000000002216
NLM
Kupa LVK, Medeiros-Ribeiro AC, Aikawa NE, Pasoto SG, Borba Neto EF, Assad APL, SAAD CGS, Shinjo SK, Silva CAA da, Bonfa ESD de O. Disease safety, immunogenicity, and efficacy of recombinant Herpes Zoster Vaccine (RZV or Shingrix) in autoimmune rheumatic diseases: launching a randomized phase 4 study [Internet]. JCR-Journal of Clinical Rheumatology. 2025 ; 31( 6): e104-e111.[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/89117
Vancouver
Kupa LVK, Medeiros-Ribeiro AC, Aikawa NE, Pasoto SG, Borba Neto EF, Assad APL, SAAD CGS, Shinjo SK, Silva CAA da, Bonfa ESD de O. Disease safety, immunogenicity, and efficacy of recombinant Herpes Zoster Vaccine (RZV or Shingrix) in autoimmune rheumatic diseases: launching a randomized phase 4 study [Internet]. JCR-Journal of Clinical Rheumatology. 2025 ; 31( 6): e104-e111.[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/89117
Artigo de periodico-carta/editorial
Doença de vias aéreas associada à artrite reumatoide.[Carta]: comportamento longitudinal da função pulmonar (2024)
Sabbag, Maria Laura Bertozo; Molina, Camila de Assis; Sawamura, Marcio Valente Yamada; Bonfiglioli, Karina; Medeiros-Ribeiro, Ana Cristina; Pugliesi, Alisson; Nakagawa, Renato Hideo; Arimura, Fabio Eiji; Athanazio, Rodrigo Abensur; Kairalla, Ronaldo Adib
Source: Jornal brasileiro de pneumologia. Unidade: FM
Subjects: ARTRITE REUMATOIDE, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SABBAG, Maria Laura Bertozo et al. Doença de vias aéreas associada à artrite reumatoide.[Carta]: comportamento longitudinal da função pulmonar. Jornal brasileiro de pneumologia. Brasilia DF: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/76882. Acesso em: 01 maio 2026. , 2024
APA
Sabbag, M. L. B., Molina, C. de A., Sawamura, M. V. Y., Bonfiglioli, K., Medeiros-Ribeiro, A. C., Pugliesi, A., et al. (2024). Doença de vias aéreas associada à artrite reumatoide.[Carta]: comportamento longitudinal da função pulmonar. Jornal brasileiro de pneumologia. Brasilia DF: Faculdade de Medicina, Universidade de São Paulo. doi:10.36416/1806-3756/e20230322
NLM
Sabbag MLB, Molina C de A, Sawamura MVY, Bonfiglioli K, Medeiros-Ribeiro AC, Pugliesi A, Nakagawa RH, Arimura FE, Athanazio RA, Kairalla RA. Doença de vias aéreas associada à artrite reumatoide.[Carta]: comportamento longitudinal da função pulmonar [Internet]. Jornal brasileiro de pneumologia. 2024 ; 50( 1):[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76882
Vancouver
Sabbag MLB, Molina C de A, Sawamura MVY, Bonfiglioli K, Medeiros-Ribeiro AC, Pugliesi A, Nakagawa RH, Arimura FE, Athanazio RA, Kairalla RA. Doença de vias aéreas associada à artrite reumatoide.[Carta]: comportamento longitudinal da função pulmonar [Internet]. Jornal brasileiro de pneumologia. 2024 ; 50( 1):[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76882
Artigo de periodico
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy (2022)
Sampaio-Barros, Percival Degrava; Medeiros-Ribeiro, Ana Cristina; Luppino-Assad, Ana Paula; Miossi, Renata; Silva, Henrique Carrico da; Yuki, Emily F. V. N; Pasoto, Sandra G; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Rheumatology. Unidade: FM
Subjects: PEDIATRIA, DOENÇAS NEONATAIS E ANORMALIDADES, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO-BARROS, Percival Degrava et al. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy. Rheumatology, v. 61, n. SI2, p. SI169-SI174, 2022Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab886. Acesso em: 01 maio 2026.
APA
Sampaio-Barros, P. D., Medeiros-Ribeiro, A. C., Luppino-Assad, A. P., Miossi, R., Silva, H. C. da, Yuki, E. F. V. N., et al. (2022). SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy. Rheumatology, 61( SI2), SI169-SI174. doi:10.1093/rheumatology/keab886
NLM
Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Silva HC da, Yuki EFVN, Pasoto SG, Saad CGS, Silva CAA da, Kupa L de VK, Bonfa ESD de O. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy [Internet]. Rheumatology. 2022 ; 61( SI2): SI169-SI174.[citado 2026 maio 01 ] Available from: https://doi.org/10.1093/rheumatology/keab886
Vancouver
Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Silva HC da, Yuki EFVN, Pasoto SG, Saad CGS, Silva CAA da, Kupa L de VK, Bonfa ESD de O. SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy [Internet]. Rheumatology. 2022 ; 61( SI2): SI169-SI174.[citado 2026 maio 01 ] Available from: https://doi.org/10.1093/rheumatology/keab886
Artigo de periodico
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (2022)
Araujo, Carlo Scognamiglio Renner; Medeiros-Ribeiro, Ana Cristina; Saad, Carla G. S; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Kupa, Leonard de Vinci Kanda ; Pereira, Rosa Maria Rodrigues ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: METOTREXATO, VACINAS VIRAIS, ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Carlo Scognamiglio Renner et al. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, v. 81, n. 6, p. 889-897, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221916. Acesso em: 01 maio 2026.
APA
Araujo, C. S. R., Medeiros-Ribeiro, A. C., Saad, C. G. S., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., et al. (2022). Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 81( 6), 889-897. doi:10.1136/annrheumdis-2021-221916
NLM
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Vancouver
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916
Artigo de periodico
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)
Aikawa, Nadia Emi; Kupa, Leonard de Vinci Kanda; Medeiros-Ribeiro, Ana Cristina; Saad, Carla Goncalves Schahin; Pereira, Rosa Maria Rodrigues ; Shinjo, Samuel Katsuyuki ; Sartori, Ana Marli Christovam ; Antonangelo, Leila ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, v. 81, n. 7, p. 1036-1043, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-222096. Acesso em: 01 maio 2026.
APA
Aikawa, N. E., Kupa, L. de V. K., Medeiros-Ribeiro, A. C., Saad, C. G. S., Pereira, R. M. R., Shinjo, S. K., et al. (2022). Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Annals of the rheumatic diseases, 81( 7), 1036-1043. doi:10.1136/annrheumdis-2021-222096
NLM
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Vancouver
Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Pereira RMR, Shinjo SK, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 7): 1036-1043.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-222096
Artigo de periodico
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
Medeiros-Ribeiro, Ana Cristina; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Silva, Henrique Carrico da; Saad, Carla G. S.; Yuki, Emily Figueiredo Neves; Pasoto, Sandra Gofinet; Araujo, Carlo Scognamiglio Renner; Nakai, Tatiane Lie; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 01 maio 2026.
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2026 maio 01 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Artigo de periodico
Association of bone erosions and osteophytes with systemic bone involvement on high-resolution peripheral quantitative computed tomography in premenopausal women with longstanding rheumatoid arthritis (2022)
Perez, Mariana O; Figueiredo, Camille P; Sales, Lucas P; Medeiros-Ribeiro, Ana Cristina; Takayama, Liliam; Domiciano, Diogo S; Bonfiglioli, Karina; Caparbo, Valeria de Falco ; Pereira, Rosa Maria Rodrigues
Source: Arthritis & rheumatology. Unidade: FM
Subjects: DENSIDADE ÓSSEA, FRATURAS, MULHERES, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Mariana O et al. Association of bone erosions and osteophytes with systemic bone involvement on high-resolution peripheral quantitative computed tomography in premenopausal women with longstanding rheumatoid arthritis. Arthritis & rheumatology, v. 74, n. 3, p. 407-417, 2022Tradução . . Disponível em: https://doi.org/10.1002/art.41961. Acesso em: 01 maio 2026.
APA
Perez, M. O., Figueiredo, C. P., Sales, L. P., Medeiros-Ribeiro, A. C., Takayama, L., Domiciano, D. S., et al. (2022). Association of bone erosions and osteophytes with systemic bone involvement on high-resolution peripheral quantitative computed tomography in premenopausal women with longstanding rheumatoid arthritis. Arthritis & rheumatology, 74( 3), 407-417. doi:10.1002/art.41961
NLM
Perez MO, Figueiredo CP, Sales LP, Medeiros-Ribeiro AC, Takayama L, Domiciano DS, Bonfiglioli K, Caparbo V de F, Pereira RMR. Association of bone erosions and osteophytes with systemic bone involvement on high-resolution peripheral quantitative computed tomography in premenopausal women with longstanding rheumatoid arthritis [Internet]. Arthritis & rheumatology. 2022 ; 74( 3): 407-417.[citado 2026 maio 01 ] Available from: https://doi.org/10.1002/art.41961
Vancouver
Perez MO, Figueiredo CP, Sales LP, Medeiros-Ribeiro AC, Takayama L, Domiciano DS, Bonfiglioli K, Caparbo V de F, Pereira RMR. Association of bone erosions and osteophytes with systemic bone involvement on high-resolution peripheral quantitative computed tomography in premenopausal women with longstanding rheumatoid arthritis [Internet]. Arthritis & rheumatology. 2022 ; 74( 3): 407-417.[citado 2026 maio 01 ] Available from: https://doi.org/10.1002/art.41961
Artigo de periodico
Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients (2022)
Gualano, Bruno ; Lemes, Ítalo Ribeiro ; Silva, Rafael Pires da ; Pinto, Ana Jessica ; Mazzolani, Bruna Caruso ; Smaira, Fabiana Infante ; Sieczkowska, Sofia Mendes ; Aikawa, Nadia Emi ; Pasoto, Sandra Gofinet ; Medeiros-Ribeiro, Ana Cristina ; Saad, Carla; Yuki, Emily F. N ; Silva, Clovis Artur ; Swinton, Paul Alan ; Hallal, Pedro Curi ; Roschel, Hamilton ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Scandinavian journal of medicine & science in sports. Unidades: FM, EEFE
Subjects: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, COVID-19, IMUNOSSUPRESSÃO, ATIVIDADE FÍSICA, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUALANO, Bruno et al. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, v. 32, n. 10, p. 1510-1515, 2022Tradução . . Disponível em: https://doi.org/10.1111/sms.14213. Acesso em: 01 maio 2026.
APA
Gualano, B., Lemes, Í. R., Silva, R. P. da, Pinto, A. J., Mazzolani, B. C., Smaira, F. I., et al. (2022). Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients. Scandinavian journal of medicine & science in sports, 32( 10), 1510-1515. doi:10.1111/sms.14213
NLM
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2026 maio 01 ] Available from: https://doi.org/10.1111/sms.14213
Vancouver
Gualano B, Lemes ÍR, Silva RP da, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad C, Yuki EFN, Silva CA, Swinton PA, Hallal PC, Roschel H, Bonfa ESD de O. Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients [Internet]. Scandinavian journal of medicine & science in sports. 2022 ; 32( 10): 1510-1515.[citado 2026 maio 01 ] Available from: https://doi.org/10.1111/sms.14213

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies